Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

BLOCKADE OF HEART 3H-NOREPINEPHRINE UPTAKE BY 4-PHENYL-1-AMINOTETRALINES: IMPLICATIONS FOR THE ACTIVE CONFORMATION OF IMIPRAMINE-LIKE DRUGS

Reinhard Sarges, B. Kenneth Koe, Albert Weissman and John P. Schaefer
Journal of Pharmacology and Experimental Therapeutics December 1974, 191 (3) 393-402;
Reinhard Sarges
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Kenneth Koe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert Weissman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John P. Schaefer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

A series of phenyl substituted 1-aminotetraline (1-amino-1,2,3,4-tetrahydronapththalene) derivatives was examined for effects on uptake of exogenous 3H-norepinephrine into rat heart and on reserpine-induced hypothermia in mice. trans-4-Phenyl derivatives with small nitrogen substituents were found to block norepinephrine uptake and to reverse reserpine-induced hypothermia with consistently greater effectiveness than their often inactive cis isomers. 1R,4S-N-methyl-4-phenyl-1,2,3,4-tetrahydro-1-naphthylamine (1aα) was the most potent uptake blocker of this series. Its enantiomer was inactive, indicating the existence of a stereospecific receptor at the norepinephrine uptake pump. The structural and functional resemblance of this compound to desipramine suggests that in the active conformation the aminoalkyl side chain of tricyclic antidepressants is folded toward the aromatic ring. This hypothesis is supported by the potent uptake blockade observed with the nontricyclic agent, EXP-561 (1-amino-4-phenylbicyclo[2.2.2]octane), and by the relative inactivity of cyproheptadine [4-(5H-dibenz-[a,d]cyclohepten-5-ylidine)-1-methylpiperidine].

Footnotes

    • Received November 19, 1973.
    • Accepted July 23, 1974.
  • © 1974 by The Williams & Wilkins Co.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 191, Issue 3
1 Dec 1974
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
BLOCKADE OF HEART 3H-NOREPINEPHRINE UPTAKE BY 4-PHENYL-1-AMINOTETRALINES: IMPLICATIONS FOR THE ACTIVE CONFORMATION OF IMIPRAMINE-LIKE DRUGS
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

BLOCKADE OF HEART 3H-NOREPINEPHRINE UPTAKE BY 4-PHENYL-1-AMINOTETRALINES: IMPLICATIONS FOR THE ACTIVE CONFORMATION OF IMIPRAMINE-LIKE DRUGS

Reinhard Sarges, B. Kenneth Koe, Albert Weissman and John P. Schaefer
Journal of Pharmacology and Experimental Therapeutics December 1, 1974, 191 (3) 393-402;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

BLOCKADE OF HEART 3H-NOREPINEPHRINE UPTAKE BY 4-PHENYL-1-AMINOTETRALINES: IMPLICATIONS FOR THE ACTIVE CONFORMATION OF IMIPRAMINE-LIKE DRUGS

Reinhard Sarges, B. Kenneth Koe, Albert Weissman and John P. Schaefer
Journal of Pharmacology and Experimental Therapeutics December 1, 1974, 191 (3) 393-402;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Discriminative Stimulus Effects of Zolpidem in Squirrel Monkeys: Comparison with Conventional Benzodiazepines and Sedative-Hypnotics
  • Powerful Activation of Skeletal Muscle Actomyosin ATPase by Goniodomin A Is Highly Sensitive to Troponin/Tropomyosin Complex
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics